Manufacturer of Controlled Substances; Notice of Application; Siegfried (USA), LLC, 1391 [2014-00053]

Download as PDF Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Parole Commission Manufacturer of Controlled Substances; Notice of Application; Siegfried (USA), LLC Sunshine Act Meeting Drug Schedule Gamma Hydroxybutyric Acid (2010). Dihydromorphine (9145) ............... Hydromorphinol (9301) ................. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Methadone intermediate (9254) ... Dextropropoxyphene, bulk (9273) Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Opium tincture (9630) .................. Oxymorphone (9652) ................... I mstockstill on DSK4VPTVN1PROD with NOTICES 12:00 p.m., Tuesday, January 14, 2014. U.S. Parole Commission, 90 K Street NE., 3rd Floor, Washington, DC PLACE: STATUS: MATTERS TO BE CONSIDERED: Determination on four original jurisdiction cases. CONTACT PERSON FOR MORE INFORMATION: Patricia W. Moore, Staff Assistant to the Chairman, U.S. Parole Commission, 90 K Street NE., 3rd Floor, Washington, DC 20530, (202) 346–7001. BILLING CODE 4410–31–P DEPARTMENT OF JUSTICE Parole Commission Sunshine Act Meeting 10:00 a.m., Tuesday, January 14, 2014. TIME AND DATE: U.S. Parole Commission, 90 K Street NE., 3rd Floor, Washington, DC PLACE: STATUS: Open. Approval of August 8, 2013 minutes; reports from the Chairman, the Commissioners, and senior staff; Short Intervention For Success Program; Proposed Rulemaking Revising Conditions of Release update. MATTERS TO BE CONSIDERED: CONTACT PERSON FOR MORE INFORMATION: Patricia W. Moore, Staff Assistant to the Chairman, U.S. Parole Commission, 90 K Street NE., 3rd Floor, Washington, DC 20530, (202) 346–7001. Dated: January 6, 2014. J. Patricia W. Smoot, Acting General Counsel, U.S. Parole Commission. [FR Doc. 2014–00167 Filed 1–6–14; 4:15 pm] BILLING CODE 4410–31–P [FR Doc. 2014–00053 Filed 1–7–14; 8:45 am] BILLING CODE 4410–09–P 16:42 Jan 07, 2014 Jkt 232001 PO 00000 Frm 00030 Fmt 4703 In the Matter of Ameren Missouri, Callaway Plant; Independent Spent Fuel Storage Installation; Order Modifying License (Effective Immediately) Nuclear Regulatory Commission. ACTION: Order; modification. AGENCY: Closed. [FR Doc. 2014–00168 Filed 1–6–14; 4:15 pm] The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than March 10, 2014. VerDate Mar<15>2010 [Docket No. 72–1045; EA–13–237; NRC– 2013–0292] Dated: January 6, 2014. J. Patricia W. Smoot, Acting General Counsel, U.S. Parole Commission. I I II II II II II II II II II II II II II II II II Dated: December 23, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. NUCLEAR REGULATORY COMMISSION TIME AND DATE: Pursuant to 21 CFR 1301.33(a), this is notice that on November 13, 2013, Siegfried (USA), LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: 1391 Sfmt 4703 The U.S. Nuclear Regulatory Commission (NRC) has issued a general license to Ameren Missouri (AmerenUE), authorizing the operation of an Independent Spent Fuel Storage Installation (ISFSI), in accordance with its regulations. This Order is being issued to AmerenUE because AmerenUE has identified near-term plans to store spent fuel in an ISFSI under the general license provisions of the NRC’s regulations. ADDRESSES: Please refer to Docket ID NRC–2013–0292 when contacting the NRC about the availability of information regarding this document. You may access publicly-available information related to this action by the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2013–0292. Address questions about NRC dockets to Carol Gallagher; telephone: 301–287–3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may access publicly available documents online in the NRC Library at https://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced in this document (if that document is available in ADAMS) is provided the first time that a document is referenced. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: L. Raynard Wharton, Office of Nuclear SUMMARY: E:\FR\FM\08JAN1.SGM 08JAN1

Agencies

[Federal Register Volume 79, Number 5 (Wednesday, January 8, 2014)]
[Notices]
[Page 1391]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00053]



[[Page 1391]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Siegfried (USA), LLC

    Pursuant to 21 CFR 1301.33(a), this is notice that on November 13, 
2013, Siegfried (USA), LLC, 33 Industrial Park Road, Pennsville, New 
Jersey 08070, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Dihydromorphine (9145).....................  I
Hydromorphinol (9301)......................  I
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Dextropropoxyphene, bulk (9273)............  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium tincture (9630)......................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance, may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODW), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than March 10, 2014.

     Dated: December 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-00053 Filed 1-7-14; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.